Idinvest in €12m round for M2i

Idinvest Growth Fund II was launched last year and held a first close on €250m in November. The GP then said it was aiming for a final close on €350-400m in Q1 2017.

Growth Fund II targets SMEs in the digital, health and energy sectors. Around 12-20 investments are planned with the vehicle, with tickets varying between €10-14m.

The fresh capital should enable M2i to finance the approval process of its biocontrol products, pursue its R&D investment strategy, speed up the commercial launch of its products, and accelerate its international development.

Company
Founded in 2013, M2i specialises in the production of pheromones for the biological protection of crops.

M2i has a research laboratory in Lacq, a production plant in Salin de Giraud and a manufacturing center in Parnac. It employs 110 people.

People
Idinvest Partners – Matthieu Baret (partner); Emmanuelle Pierret (investment director).
M2i – Philippe Guerret (president).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Healthcare
• France
• Venture
• France
• IDInvest Partners (AGF Private Equity)